Skip to menu Skip to content Skip to footer
Honorary Professor Josephine Forbes
Honorary Professor

Josephine Forbes

Email: 

Overview

Availability

Honorary Professor Josephine Forbes is:
Available for supervision

Qualifications

  • Bachelor, University of Melbourne
  • Doctor of Philosophy, University of Melbourne

Works

Search Professor Josephine Forbes’s works on UQ eSpace

259 works between 1995 and 2025

81 - 100 of 259 works

2016

Journal Article

Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes

Coughlan, Melinda T., Nguyen, Tuong-Vi, Penfold, Sally A., Higgins, Gavin C., Thallas-Bonke, Vicki, Tan, Sih Min, Van Bergen, Nicole J., Sourris, Karly C., Harcourt, Brooke E., Thorburn, David R., Trounce, Ian A., Cooper, Mark E. and Forbes, Josephine M. (2016). Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes. Clinical Science, 130 (9), 711-720. doi: 10.1042/CS20150838

Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes

2016

Journal Article

Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial

Rossi, Megan, Johnson, David W., Morrison, Mark, Pascoe, Elaine M., Coombes, Jeff S., Forbes, Josephine M., Szeto, Cheuk-Chun, McWhinney, Brett C., Ungerer, Jacobus P. J. and Campbell, Katrina L. (2016). Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial. Clinical Journal of the American Society of Nephrology, 11 (2), 223-231. doi: 10.2215/CJN.05240515

Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial

2016

Journal Article

Tapping into mitochondria to find novel targets for diabetes complications

Fleming, Nicole B., Gallo, Linda, Ward, Micheal S. and Forbes, Josephine M. (2016). Tapping into mitochondria to find novel targets for diabetes complications. Current Drug Targets, 17 (12), 1341-1349. doi: 10.2174/1389450116666150727114410

Tapping into mitochondria to find novel targets for diabetes complications

2015

Journal Article

Abdominal obesity and brain atrophy in type 2 diabetes mellitus

Climie, Rachel E. D., Moran, Chris, Callisaya, Michele, Blizzard, Leigh, Sharman, James E., Venn, Alison, Phan, Thanh G., Beare, Richard, Forbes, Josephine, Blackburn, Nicholas B. and Srikanth, Velandai (2015). Abdominal obesity and brain atrophy in type 2 diabetes mellitus. PloS One, 10 (11) e0142589, e0142589. doi: 10.1371/journal.pone.0142589

Abdominal obesity and brain atrophy in type 2 diabetes mellitus

2015

Conference Publication

IL-22-mediated suppression of islet inflammation

McGuckin, Mike, Hasnain, Sumaira Z., Borg, Danielle J., Loudovaris, Thomas, Kay, Thomas W., Thomas, Helen E., Whitehead, Jonathon P., Forbes, Josephine M. and Prins, John B. (2015). IL-22-mediated suppression of islet inflammation. IPITA/IXA/CTS Joint Congress, Melbourne Australia, Nov 15-19, 2015. HOBOKEN: LIPPINCOTT WILLIAMS & WILKINS.

IL-22-mediated suppression of islet inflammation

2015

Conference Publication

Human soluble receptor for advanced glycation end products therapy reduces autoimmune diabetes in the non-obese diabetic mouse

Leung, S. S.-Y., Borg, D. J., McCarthy, D., Zhuang, A., Fotheringham, A., Di Trapani, G., Groop, P.-H., Knip, M. and Forbes, J. (2015). Human soluble receptor for advanced glycation end products therapy reduces autoimmune diabetes in the non-obese diabetic mouse. Joint Annual Conference of the International Society for Pediatric and Adolescent Diabetes and Australasian Paediatric Endocrine Group (ISPAD+APEG 2015), Brisbane, QLD Australia, 7-10 October 2015. Hoboken, NJ USA: Wiley-Blackwell Publishing. doi: 10.1111/pedi.12309

Human soluble receptor for advanced glycation end products therapy reduces autoimmune diabetes in the non-obese diabetic mouse

2015

Conference Publication

Gene Therapy Using Recombinant Adeno-Associated Virus Serotype 2/8 Liver-Directed Expression of Srage in Experimental Type 1 Diabetes

Leung, Sherman S., Borg, Danielle J., Paul, Moumita, Sharland, Alexandra F. and Forbes, Josephine M. (2015). Gene Therapy Using Recombinant Adeno-Associated Virus Serotype 2/8 Liver-Directed Expression of Srage in Experimental Type 1 Diabetes. 9th Biennial Meeting of the Australasian-Gene-and-Cell-Therapy-Society (AGCTS), Parkville, VIC Australia, 29 April - 1 May 2015. Hoboken, NJ United States: Wiley-Blackwell.

Gene Therapy Using Recombinant Adeno-Associated Virus Serotype 2/8 Liver-Directed Expression of Srage in Experimental Type 1 Diabetes

2015

Journal Article

Dietary advanced glycation end products consumption as a direct modulator of insulin sensitivity in overweight humans: a study protocol for a double-blind, randomized, two period cross-over trial

de Courten, Barbora, de Courten, Maximilian P. J., Schalkwijk, Casper G., Walker, Karen Z. and Forbes, Josephine (2015). Dietary advanced glycation end products consumption as a direct modulator of insulin sensitivity in overweight humans: a study protocol for a double-blind, randomized, two period cross-over trial. JMIR Research Protocols, 4 (3) e93, e93+. doi: 10.2196/resprot.4552

Dietary advanced glycation end products consumption as a direct modulator of insulin sensitivity in overweight humans: a study protocol for a double-blind, randomized, two period cross-over trial

2015

Conference Publication

Recombinant human soluble receptor for advanced glycation end product therapy reduces autoimmune diabetes in the NOD mouse model

Leung, Sherman, Borg, Danielle J., McCarthy, Domenica, Zhuang, Aowen, Forbes, Josephine and Ward, Micheal (2015). Recombinant human soluble receptor for advanced glycation end product therapy reduces autoimmune diabetes in the NOD mouse model. 75th Scientific Sessions of the American-Diabetes-Association, Boston, MA United States, 5-9 June 2015. Alexandria, VA United States: American Diabetes Association.

Recombinant human soluble receptor for advanced glycation end product therapy reduces autoimmune diabetes in the NOD mouse model

2015

Conference Publication

Synbiotic therapy in pre-dialysis: a randomised controlled trial

Rossi, Megan, Johnson, David, Pascoe, Elaine, Coombes, Jeff, Forbes, Josephine, Szeto, Cheuk-Chun, McWhinney, Brett, Ungerer, Jacobus and Campbell, Katrina (2015). Synbiotic therapy in pre-dialysis: a randomised controlled trial. 52nd ERA-EDTA Congress, London, United Kingdom, 28-31 May 2015. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfv152.02

Synbiotic therapy in pre-dialysis: a randomised controlled trial

2015

Journal Article

Decrease in circulating concentrations of soluble receptors for advanced glycation end products at the time of seroconversion to autoantibody positivity in children with prediabetes

Salonen, Kirsi M., Ryhanen, Samppa J., Forbes, Josephine M., Borg, Danielle J., Harkonen, Taina, Ilonen, Jorma, Simell, Olli, Veijola, Riitta, Groop, Per-Henrik and Knip, Mikael (2015). Decrease in circulating concentrations of soluble receptors for advanced glycation end products at the time of seroconversion to autoantibody positivity in children with prediabetes. Diabetes Care, 38 (4), 665-670. doi: 10.2337/dc14-1186

Decrease in circulating concentrations of soluble receptors for advanced glycation end products at the time of seroconversion to autoantibody positivity in children with prediabetes

2015

Journal Article

A rapid extraction method for glycogen from formalin-fixed liver

Sullivan, Mitchell A., Li, Shihan, Aroney, Samuel T.N., Deng, Bin, Li, Cheng, Roura, Eugeni, Schulz, Benjamin L., Harcourt, Brooke E., Forbes, Josephine M. and Gilbert, Robert G. (2015). A rapid extraction method for glycogen from formalin-fixed liver. Carbohydrate Polymers, 118, 9-15. doi: 10.1016/j.carbpol.2014.11.005

A rapid extraction method for glycogen from formalin-fixed liver

2015

Journal Article

Impairment of liver glycogen storage in the db/db animal model of type 2 diabetes: a potential target for future therapeutics?

Sullivan, Mitchell A., Harcourt, Brooke E., Xu, Ping, Forbes, Josephine M. and Gilbert, Robert G. (2015). Impairment of liver glycogen storage in the db/db animal model of type 2 diabetes: a potential target for future therapeutics?. Current Drug Targets, 16 (10), 1088-1093. doi: 10.2174/1389450116666150727123115

Impairment of liver glycogen storage in the db/db animal model of type 2 diabetes: a potential target for future therapeutics?

2015

Conference Publication

Synbiotic Therapy in Pre-Dialysis: a Randomised Controlled Trial

Rossi, Megan, Johnson, David, Pascoe, Elaine, Coombes, Jeff, Forbes, Josephine, Szeto, Cheuk-Chun, McWhinney, Brett, Ungerer, Jacobus and Campbell, Katrina (2015). Synbiotic Therapy in Pre-Dialysis: a Randomised Controlled Trial. 52nd Congress of the European-Renal-Association-European-Dialysis-and-Transplant-Assocation, London England, 28-31 May 2015. United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfv152.2

Synbiotic Therapy in Pre-Dialysis: a Randomised Controlled Trial

2015

Journal Article

Type 2 diabetes, skin autofluorescence, and brain atrophy

Moran, C., Munch, G., Forbes, J.M., Beare, R., Blizzard, L., Venn, A.J., Phan, T.G., Chen, J. and Srikanth, V. (2015). Type 2 diabetes, skin autofluorescence, and brain atrophy. Diabetes, 64 (1), 279-283. doi: 10.2337/db14-0506

Type 2 diabetes, skin autofluorescence, and brain atrophy

2015

Conference Publication

Short-term alagebrium chloride (ALT-711) therapy pre-diabetes for the treatment of Type I Diabetes

Borg, D. J., McCarthy, D., Reeves, P., Ward, M. S., Fotheringham, A. K., Gallo, L. A., Harcourt, B. E., Agrawal, N., Steptoe, R. and Forbes, J. M. (2015). Short-term alagebrium chloride (ALT-711) therapy pre-diabetes for the treatment of Type I Diabetes. Immunology of Diabetes Society 14th International Congress, Munich, Germany, 12-16 April 2015.

Short-term alagebrium chloride (ALT-711) therapy pre-diabetes for the treatment of Type I Diabetes

2015

Conference Publication

Delivery of recombinant human soluble receptor for advanced glycation end products delays autoimmune diabetes in the NOD mouse model

Borg, D. J., Leung, S., Zhuang, A., Fotheringham, A., McCarthy, D., Di Trapani, J., Groop, P. -H., Knip, M. and Forbes, J. (2015). Delivery of recombinant human soluble receptor for advanced glycation end products delays autoimmune diabetes in the NOD mouse model. 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Stockholm, Sweden, 14-18 September 2015. Heidelberg, Germany: Springer. doi: 10.1007/s00125-015-3687-4

Delivery of recombinant human soluble receptor for advanced glycation end products delays autoimmune diabetes in the NOD mouse model

2015

Journal Article

Contrasting association of circulating sCD14 with insulin sensitivity in non-obese and morbidly obese subjects

de Courten, Barbora, Moreno-Navarrete, Jose Maria, Lyons, Jasmine, Soldatos, Georgia, de Courten, Maximilian, Dougherty, Sonia, Forbes, Josephine and Fernandez-Real, Jose Manuel (2015). Contrasting association of circulating sCD14 with insulin sensitivity in non-obese and morbidly obese subjects. Molecular Nutrition and Food Research, 60 (1), 103-109. doi: 10.1002/mnfr.201500102

Contrasting association of circulating sCD14 with insulin sensitivity in non-obese and morbidly obese subjects

2015

Conference Publication

In Db/db mice, Sglt2 inhibition does not improve diabetic nephropathy despite glycaemic improvements

Gallo, L. A., Ward, M. S., Fotheringham, A. K., Pollock, C., Panchapakesan, U. and Forbes, J. M. (2015). In Db/db mice, Sglt2 inhibition does not improve diabetic nephropathy despite glycaemic improvements. 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Canberra, Australia, 7-9 September 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12543

In Db/db mice, Sglt2 inhibition does not improve diabetic nephropathy despite glycaemic improvements

2015

Conference Publication

IL-22-MEDIATED SUPPRESSION OF ISLET INFLAMMATION

McGuckin, Mike, Hasnain, Sumaira Z., Borg, Danielle J., Loudovaris, Thomas, Kay, Thomas W., Thomas, Helen E., Whitehead, Jonathon P., Forbes, Josephine M. and Prins, John B. (2015). IL-22-MEDIATED SUPPRESSION OF ISLET INFLAMMATION. Joint Congress of the International-Pancreas-and-Islet-Transplantation-Association, International-Xenotransplantation-Association and Cell-Transplant-Society, Melbourne Australia, Nov 15-19, 2015. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

IL-22-MEDIATED SUPPRESSION OF ISLET INFLAMMATION

Funding

Current funding

  • 2024 - 2026
    Understanding RAGE Expression and Function in Human T and Dendritic Cells to Refine the Use of RAGE Targeting Therapeutics for Type 1 Diabetes Prevention
    Juvenile Diabetes Research Foundation - International
    Open grant
  • 2022 - 2026
    Designing and translating novel therapies for diabetes and kidney disease
    NHMRC Investigator Grants
    Open grant

Past funding

  • 2021 - 2024
    Innovative delivery methods for the biologic soluble RAGE to prevent Type 1 Diabetes
    JDRF Pilot and Innovation Awards
    Open grant
  • 2019 - 2021
    RAGE as a novel therapeutic target for T1D
    Juvenile Diabetes Research Foundation - International
    Open grant
  • 2019
    Dissolution DNP Hyperpolariser
    UQ Research Facilities Infrastructure Grants
    Open grant
  • 2019 - 2021
    Preventing progression of diabetic kidney disease by targeting mitochondrial function
    NHMRC Project Grant
    Open grant
  • 2016 - 2017
    Genetic susceptibility to mitochondrial dysfunction as a risk factor for diabetic nephropathy (DiaComp - NIH subaward administered by Augusta University)
    Augusta University
    Open grant
  • 2016 - 2018
    Advanced Glycation in the development of T1D (Helmsley Charitable Trust - George Eisenbath nPOD award for team science) - Administered by the University of Miami
    University of Miami
    Open grant
  • 2016 - 2020
    Investigating pathways to alleviate the burden of diabetes and kidney disease
    NHMRC Research Fellowship
    Open grant
  • 2016
    Mitochondrial dysfunction as a mediator of diabetic kidney disease
    Diabetes Australia Research Program
    Open grant
  • 2015 - 2018
    Environmental Determinants of Islet Autoimmunity (ENDIA) (University of Adelaide led JDRF Australian Type 1 Diabetes Clinical Research Network (T1DCRN) RFA )
    University of Adelaide
    Open grant
  • 2015 - 2017
    Kidney energetics in the development of nephropathy in type 1 diabetes (DiaComp - NIH subaward administered by Augusta University)
    Augusta University
    Open grant
  • 2015
    Glucose transport in the diabetic kidney
    Diabetes Australia Research Trust
    Open grant
  • 2015 - 2019
    IL-22 as a Suppressor of Pancreatic Beta-Cell Stress and a Treatment for Diabetes
    NHMRC Project Grant
    Open grant
  • 2014 - 2016
    Urinary metabolic profiles as predictors of early diabetic nephropathy
    Kidney Health Australia
    Open grant
  • 2013 - 2014
    Identification of a novel target for the treatment of diabetic kidney disease
    NHMRC Project Grant
    Open grant
  • 2013 - 2014
    Modern food processing as a contributor to type 1 diabetes
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    NHMRC Research Fellowship (SRF A): Delineating the role of advanced glycation in diabetes and nephropathy
    NHMRC Research Fellowship
    Open grant

Supervision

Availability

Honorary Professor Josephine Forbes is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Honorary Professor Josephine Forbes's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au